Zunveyl is supplied as 5mg, 10mg, and 15mg delayed-release tablets, which can be taken with or without food. Zunveyl ® (benzgalantamine) is now available for the treatment of mild to moderate dementia ...
Please provide your email address to receive an email when new articles are posted on . High FeNO levels indicate exacerbation and lung function risks. Most patients with high FeNO levels also had ...
Dr. Myron Czuczman highlighted the significance of the recent U.S. Food and Drug Administration (FDA) approval of Lymphir ...
Efinaconazole 10% solution was found to be a safe and effective treatment of chronic fungal nail infections among patients with skin of color, according to a study published in the Journal of Drugs in ...
ORO VALLEY, Ariz. (KGUN) — They say seeing is believing, but hearing can be life-changing, too. Apple’s AirPods Pro 2 could soon help those with mild to moderate hearing loss, according to Sally ...
"What should I eat?" is perhaps the most common question patients with inflammatory bowel disease ask their doctors. It's notoriously difficult to answer. There have been few large studies of dietary ...
Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV-6 trial showed. After receiving ...
A mindfulness-based cognitive therapy self-help (MBCT-SH) intervention in which patients were supported by a trained practitioner led to better clinical outcomes at lower cost than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results